Terns Pharmaceuticals announced the appointment of Amy Burroughs as chief executive officer, CEO, effective immediately. Burroughs will also join the Terns board of directors. Most recently, Burroughs served as CEO at Cleave Therapeutics.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on TERN:
- Terns Pharmaceuticals Appoints Amy Burroughs as Chief Executive Officer
- Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)
- Terns Pharmaceuticals to Highlight 2024 Priorities and Clinical Milestones at the 42nd Annual J.P. Morgan Healthcare Conference
- Terns Pharmaceuticals management to meet with JMP Securities